Researchers in Oxford have been awarded £1.8m in capital funding from the Department of Health and Social Care to expand their work to tackle the growing problem of antimicrobial resistance (AMR), including using whole genome sequencing to diagnose AMR.
The funding was awarded to the NIHR (National Institute of Health Research) Oxford Biomedical Research Centre (BRC) to introduce new technologies for faster, more cost-effective sequencing of micro-organisms.